Physician profile
Stephen D Keefe
NPI 1700853066
$1,405.33
in general payments reported to CMS, 2019-2025
18 companies · $66.87 in 2025
The $66.87 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $191 · 2020: $232 · 2021: $137 · 2022: $276 · 2023: $54.73 · 2024: $448 · 2025: $66.87.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $570.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $569.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerin Medical INC. | $629.79 | 2019-2024 | |
| Glaxosmithkline, LLC. | $109.75 | 2021-2024 | Nucala |
| Stryker Corporation | $92.95 | 2019-2020 | |
| Allergan, INC. | $90.34 | 2019 | |
| Inspire Medical Systems, INC. | $79.44 | 2023-2025 | Inspire |
| Kaleo, INC. | $65.26 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $62.77 | 2021-2023 | Dupixent |
| Optinose US, INC. | $59.10 | 2020-2025 | |
| Intersect Ent, INC. | $35.15 | 2020 | |
| Medtronic, INC. | $30.76 | 2021-2022 | |
| Genzyme Corporation | $29.81 | 2021 | |
| Integra Lifesciences Corporation | $22.30 | 2025 | Inspira Air, Acclarent Aera, Trudi Probe |
| Novartis Pharmaceuticals Corporation | $21.66 | 2020 | |
| Becton, Dickinson and Company | $18.15 | 2019 | |
| Acclarent, INC | $16.47 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phadia US INC. | $15.89 | 2019 | |
| Csl Behring | $13.18 | 2020 | |
| Pharming Healthcare, INC. | $12.56 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Keefe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.